CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 92 filers reported holding CTI BIOPHARMA CORP in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,379 | -30.2% | 566,487 | -0.0% | 0.94% | -27.4% |
| Q4 2022 | $3,406 | -99.9% | 566,687 | 0.0% | 1.29% | -7.3% |
| Q3 2022 | $3,298,000 | -2.5% | 566,687 | 0.0% | 1.39% | -2.3% |
| Q2 2022 | $3,383,000 | +30.1% | 566,687 | +1.8% | 1.42% | +71.6% |
| Q1 2022 | $2,600,000 | +374.5% | 556,687 | +151.8% | 0.83% | +345.2% |
| Q4 2021 | $548,000 | – | 221,079 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Legal & General Group Plc | 9,340 | $84,901 | 0.00% |
| UBS ASSET MANAGEMENT AMERICAS INC | 92,700 | $389,340 | 0.00% |
| FNY Investment Advisers, LLC | 20 | $0 | 0.00% |